Precigen, Inc. (PGEN)
5.065
-0.18
(-3.52%)
USD |
NASDAQ |
Nov 04, 16:00
4.86
-0.20
(-4.05%)
After-Hours: 17:21
Precigen Total Return Price : 5.065 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 5.25 |
| November 02, 2026 | 5.14 |
| October 30, 2026 | 6.94 |
| October 29, 2026 | 6.64 |
| October 28, 2026 | 6.08 |
| October 27, 2026 | 6.15 |
| October 26, 2026 | 6.04 |
| October 23, 2026 | 6.19 |
| October 22, 2026 | 6.39 |
| October 21, 2026 | 6.60 |
| October 20, 2026 | 6.83 |
| October 19, 2026 | 6.66 |
| October 16, 2026 | 6.385 |
| October 15, 2026 | 7.195 |
| October 14, 2026 | 7.355 |
| October 13, 2026 | 7.48 |
| October 12, 2026 | 7.66 |
| October 09, 2026 | 7.81 |
| October 08, 2026 | 7.60 |
| October 07, 2026 | 7.54 |
| October 06, 2026 | 7.55 |
| October 05, 2026 | 7.74 |
| October 02, 2026 | 8.54 |
| October 01, 2026 | 8.21 |
| September 30, 2026 | 8.56 |
| Date | Value |
|---|---|
| September 29, 2026 | 8.05 |
| September 28, 2026 | 7.81 |
| September 25, 2026 | 7.75 |
| September 24, 2026 | 7.70 |
| September 23, 2026 | 7.44 |
| September 22, 2026 | 7.89 |
| September 21, 2026 | 7.70 |
| September 18, 2026 | 7.78 |
| September 17, 2026 | 7.87 |
| September 16, 2026 | 7.435 |
| September 15, 2026 | 7.00 |
| September 14, 2026 | 6.85 |
| September 11, 2026 | 6.85 |
| September 10, 2026 | 6.68 |
| September 09, 2026 | 6.80 |
| September 08, 2026 | 6.87 |
| September 04, 2026 | 7.10 |
| September 03, 2026 | 7.14 |
| September 02, 2026 | 7.01 |
| September 01, 2026 | 6.86 |
| August 31, 2026 | 6.93 |
| August 28, 2026 | 6.95 |
| August 27, 2026 | 7.19 |
| August 26, 2026 | 7.42 |
| August 25, 2026 | 7.28 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Anika Therapeutics, Inc. | 20.37 |
| Aldeyra Therapeutics, Inc. | 0.65 |
| Repligen Corp. | 178.20 |
| AC Immune SA | 2.28 |
| Amgen, Inc. | 478.34 |